ArticleCancer control : journal of the Moffitt Cancer Center

Validation of a Prognostic Nomogram for Patients with Metastatic Pancreatic Cancer Treated with Nanoliposomal Irinotecan as Second-Line Therapy.

Yu-Shin Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.